Pemphigus is a fatal
autoimmune disease in which autoimmunoglobulins PV-
IgG (binding to
desmoglein 3) and PF-
IgG (binding to
desmoglein 1) in
pemphigus vulgaris and
pemphigus foliaceus, respectively, cause intraepidermal
blisters, cell-cell separation (
acantholysis), and cell death. The mechanism of acantholytic lesion formation has not yet been elucidated. Recently, we have reported that an apoptotic mechanism might be operative in PV-
IgG-induced
acantholysis: (1) in patients' lesional and some perilesional skin portions, the FasR pathway is activated as its components were enriched; (2) in cultured keratinocytes, PV-
IgG upregulates effectors of the FasR pathway (including the mitochondrial loop), as found by immunodetermination (cytochemistry, Western blot of pathway effectors) and determination of
caspases 1, 3, and 8 activity/activation; (3) in organ cultures of skin incubated with PV-
IgG, activated
caspase 8 was found also in perilesional cells and coaggregated with bound PV-
IgG; (4)
caspase 8 activation in DISCs precedes
caspase 3 activation in keratinocytes in cultures upon incubation with PV-
IgG. Because
caspase activation was shown to accompany lesion formation in cell and organ cultures incubated with PV-
IgG, we used
caspase activity to monitor the pathogenicity of PV-
IgG in relation to PV-
IgG binding to epithelia. A rough correlation was found between sera titers, determined by IIF and by immunoblot binding to
desmoglein 3, and activation of
caspase 3.